Top Markets
Coin of the day
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc.

AURX
Rank in Stocks #25544
Nuo Therapeutics, Inc. operates as a regenerative medicine company,... Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineered to leverage the human body's inherent capacity for natural healing, with a primary focus on the United States market. Central to their offerings is a technology that isolates components from a patient's own blood (autologous) to generate a platelet-based therapy, specifically tailored for the treatment of chronic wounds. Established in Houston, Texas, in 1998, the company underwent a name change from Cytomedix, Inc. to Nuo Therapeutics, Inc. in November 2014.
Share Price
$1.00
Last synced: 2026-08-19
Market Cap
$48.41M
Change (1 day)
0.00%
Change (1 year)
-41.86%
Country
US
Trade Nuo Therapeutics, Inc. (AURX)

Category

Number of shares outstanding for Nuo Therapeutics, Inc. (AURX)
Number of shares outstanding as of August 2026: 0
According to Nuo Therapeutics, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Nuo Therapeutics, Inc. (AURX) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
483.58M -
AU
- -
CH
396.00M -
US